Is Lopinavir and Ritonavir Oral Solution (Kaletra) in shortage?
Lopinavir and Ritonavir Oral Solution is listed by FDA as being discontinued by at least one maker (updated Jul 24, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46)
Discontinuation of the manufacture of the drug
Maker contact: 800-633-9110
FDA recalls of the same active ingredient
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Lopinavir and Ritonavir Oral Solution:
Other forms on FDA’s list
Lopinavir and Ritonavir Oral Solution shortage questions
Is Lopinavir and Ritonavir Oral Solution (Kaletra) in shortage?
Lopinavir and Ritonavir Oral Solution is listed by FDA as being discontinued by at least one maker (updated Jul 24, 2026).
What should I do if I can’t get Lopinavir and Ritonavir Oral Solution?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.